Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 10 matching records.
10 results — page 1 of 1
- Level DNarrative ReviewPubMed
Cardiac Repair and Mesenchymal Stem Cells: Exploring New Frontiers in Regenerative Medicine.
Narrative Review on Cardiovascular Disease, Immune Modulation, published in Curr Cardiol Rev (2026) — summary generated from the PubMed abstract.
- 2026
Curr Cardiol Rev - Level DLaboratory StudyPubMed
Mesenchymal Stem Cell-Derived Exosomes: A Novel Frontier in Regenerative Medicine and Immunotherapy.
Laboratory Study on Immune Modulation, published in Curr Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Curr Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
Advances in Drug Delivery Integrated with Regenerative Medicine: Innovations, Challenges, and Future Frontiers
Narrative Review, published in Pharmaceutics (2025) — summary generated from the PubMed abstract.
- 2025
Pharmaceutics24 citations - Level DNarrative ReviewEurope PMC
New frontiers of tendon augmentation technology in tissue engineering and regenerative medicine: a concise literature review
Narrative Review on Tendon Injury, Ligament Injury, Scar, published in J Int Med Res (2022) — summary generated from the PubMed abstract.
- 2022
J Int Med Res5 citations - Level BClinical TrialPubMed
Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine.
Clinical Trial on Face & Skin, published in Curr Med Chem (2021) — summary generated from the PubMed abstract.
- 2021
Curr Med Chem - Level DNarrative ReviewEurope PMC
Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier for Regenerative Medicine?
Narrative Review, published in Cells (2020) — summary generated from the PubMed abstract.
- 2020
Cells62 citations - Level BClinical TrialEurope PMC
Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?
Clinical Trial, published in Cells (2020) — summary generated from the PubMed abstract.
- 2020
Cells46 citations - Level DNarrative ReviewEurope PMC
3D Bioprinting at the Frontier of Regenerative Medicine, Pharmaceutical, and Food Industries
Narrative Review, published in Front Med Technol (2020) — summary generated from the PubMed abstract.
- 2020
Front Med Technol50 citations - Level DNarrative ReviewPubMed
New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells.
Narrative Review on Cardiovascular Disease, Immune Modulation, published in Curr Stem Cell Res Ther (2013) — summary generated from the PubMed abstract.
- 2013
Curr Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells
Narrative Review on Hip, published in Hum Gene Ther (2013) — summary generated from the PubMed abstract.
- 2013
Hum Gene Ther22 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406